Samyang Holdings's Croquis® Shows New Clinical Cases of PDO thread lift at AMWC 2024

April 03, 2024 12:30 PM AEDT | By Cision

Google News:

Samyang Holdings's Croquis® Shows New Clinical Cases of PDO thread lift at AMWC 2024 — Image source: Kalkine Media

Recent News

INSERTING AND REPLACING Woodside and Aramco Sign Collaboration Agreeme...

Telstra and Accenture Launch Silicon Valley Hub to Rapidly Advance Ben...

Flight Centre and Santos: Key Stocks to Watch in the ASX200 for 2025

Is Bendigo Bank Undervalued? Exploring BEN Stock Valuation Within the...

Sharing Clinical Cases of "Croquis® at AMWC 2024 in Monaco.
Expand market with proven safety and efficacy, 29 countries worldwide.
"Croquis®" Lifting Threads with Samyang' 25 years Expertise in Global Biodegradable Suture Threads.

SEOUL, South Korea, April 3, 2024 /PRNewswire/ -- Samyang Holdings has accelerated its global market penetration with its aesthetics product portfolio developed through its R&D technology.

Samyang Holdings announced a new clinical case of PDO thread lift Croquis® at AMWC 2024 on March 29. Dr. Mark Holmes is presenting.

Samyang Holdings Biopharm Group (CEO Young-joon Lee) presented clinical case studies of the PDO thread lift to promote the excellence of Croquis® at the Aesthetic and Anti-Aging Medicine World Congress (AMWC) in Monaco from March 27 to 29, 2024.

The presentations were led by Dr. Clara Santos (Brazil) and Dr. Mark Holmes (UK), who shared the product's unique features and their expertise through Croquis® case studies.

Dr. Clara Santos presented "Block Repositioning of Face and Neck Together with Croquis® Molding and Mono" highlighting tailored surgical techniques and the characteristics of Croquis® products. Following this, Dr. Mark Holmes shared his 12 years of experience in "How to Perform Long Lasting Cog Thread Lifts For The Face and Neck Safely and Effectively" offering insights into product selection, surgical techniques, and strategies for continuous outcome improvement, including minimizing complications and side effects.

Croquis® is a PDO biodegradable lifting thread that encapsulates over 25 years of Samyang's expertise in the field of biodegradable suture threads. It received CE MDD certification in 2019, demonstrating its excellence and safety by sharing case studies at various international academic conferences. It has secured sales contracts in 29 countries worldwide, including the EU and Japan, with ongoing efforts to expand its reach.

Samyang Holdings also promotes its patented biodegradable polymer filler, Lafullen®, Polycaprolactone (PCL) based dermal filler. It provides natural volume for two years with minimal foreign body reaction.

Samyang Holdings CEO Young-joon Lee stated "The safety and efficacy of Croquis® and Lafullen® have been proven at numerous international academic conferences, significantly raising global interest in both products. We plan to further expand our global presence through research and clinical cases."

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.